Interferon-γ and infectious diseases: Lessons and prospects

JL Casanova, JD MacMicking, CF Nathan - Science, 2024 - science.org
Infectious diseases continue to claim many lives. Prevention of morbidity and mortality from
these diseases would benefit not just from new medicines and vaccines but also from a …

Integrated organ immunity: a path to a universal vaccine

B Pulendran - Nature Reviews Immunology, 2024 - nature.com
Here, I introduce the concept of 'integrated organ immunity'to explain how the innate and
adaptive immune systems and non-haematopoietic cells can interact in tissues to generate …

Co-infection of mice with SARS-CoV-2 and Mycobacterium tuberculosis limits early viral replication but does not affect mycobacterial loads

PJ Baker, EP Amaral, E Castro, AC Bohrer… - Frontiers in …, 2023 - frontiersin.org
Viral co-infections have been implicated in worsening tuberculosis (TB) and during the
COVID-19 pandemic, the global rate of TB-related deaths has increased for the first time in …

BCG mediated protection of the lung against experimental SARS-CoV-2 infection

KL Hilligan, S Namasivayam, A Sher - Frontiers in Immunology, 2023 - frontiersin.org
The observation of reduced COVID-19 incidence and severity in populations receiving
neonatal intradermal BCG vaccination vaccine raised the question of whether BCG can …

Vaccines and dementia: part I. Non-specific immune boosting with BCG: history, ligands, and receptors

CL Greenblatt, R Lathe - Journal of Alzheimer's Disease, 2024 - content.iospress.com
Abstract Vaccines such as Bacille Calmette–Guérin (BCG) can apparently defer dementia
onset with an efficacy better than all drugs known to date, as initially reported by Gofrit et …

IL-10 suppresses T cell expansion while promoting tissue-resident memory cell formation during SARS-CoV-2 infection in rhesus macaques

CE Nelson, TW Foreman, ER Fukutani… - PLoS …, 2024 - journals.plos.org
The regulation of inflammatory responses and pulmonary disease during SARS-CoV-2
infection is incompletely understood. Here we examine the roles of the prototypic pro-and …

Mutations in nonstructural proteins essential for pathogenicity in SARS-CoV-2-infected mice

R Pan, P Li, DK Meyerholz, S Perlman - Journal of Virology, 2024 - Am Soc Microbiol
ABSTRACT Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome-coronavirus-2 (SARS-CoV-2) has resulted in substantial morbidity and mortality …

Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming

BD Williams, D Ferede, HFM Abdelaal… - Frontiers in …, 2024 - frontiersin.org
At the beginning of the COVID-19 pandemic those with underlying chronic lung conditions,
including tuberculosis (TB), were hypothesized to be at higher risk of severe COVID-19 …

[HTML][HTML] Effect of anti-COVID-19 drugs on patients with cancer

W Huang, W Liu, T Yu, Z Zhang, L Zhai… - European Journal of …, 2024 - Elsevier
The clinical treatment of patients with cancer who are also diagnosed with coronavirus
disease (COVID-19) has been a challenging issue since the outbreak of COVID-19 …

Assessing the Potential of an Enzymatically Liberated Salmon Oil to Support Immune Health Recovery from Acute SARS-CoV-2 Infection via Change in the …

C Currie, TÅ Myklebust, C Bjerknes… - International Journal of …, 2024 - mdpi.com
Cytokines, chemokines, and interferons are released in response to viral infection with the
ultimate aim of viral clearance. However, in SARS-CoV-2 infection, there is an imbalanced …